Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses

v3.22.1
Research and Development Expenses
12 Months Ended
Dec. 31, 2021
Research and Development [Abstract]  
RESEARCH AND DEVELOPMENT EXPENSES
NOTE 13 - RESEARCH AND DEVELOPMENT EXPENSES

 

Composition:

 

    Year ended
December 31,
    Year ended
December 31,
 
    2021     2020  
             
Payroll and related benefits (including share-based compensation)     3,748       2,273  
Raw materials subcontracted work and consulting     1,440       1,058  
Others     689       478  
      5,877       3,809